NNNN
Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology Class A Ordinary Shares (NNNN) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 23.7 (oversold), with 0/3 trend checks passing.
NNNN with MA50 and MA200
Key levels & signals
Anbio Biotechnology Class A Ordinary Shares (NNNN) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $9.12, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 56.9% and below the 200-day moving average by 64.4%.
NNNN currently has an RSI reading of 23.7, which places it in a deeply oversold zone. That can sometimes lead to bounce-watch setups, but it can also reflect genuine weakness, so the chart still needs proper confirmation rather than hope alone.
For traders reviewing NNNN next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Learn the indicators behind this page
More stock opportunities
Common questions about NNNN
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.